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Abstract
Background: Non-islet cell tumor hypoglycemia (NICTH) is defined as a form of hypoglycemia caused by an
extrapancreatic tumor. Solitary fibrous tumor (SFT) associated with hypoglycemia is rare.
Case presentation: A 76-year-old woman, who had frequently experienced hypoglycemic symptoms such as
presyncope for the prior 6 months, visited our hospital to undergo detailed examinations. Her fasting glucose level
was low at 49 mg/dl. The blood levels of IRI and C-peptide were also low at 0.2 μU/ml and 0.21 ng/ml, respectively.
Chest computed tomography revealed a mass measuring 15 cm in the left thoracic cavity. Percutaneous needle
biopsy yielded a diagnosis of intrathoracic SFT associated with NICTH. The tumor was removed by video-assisted
thoracoscopic surgery. Histological examination showed a tumor composed of simple spindle-shaped cells with an
irregular arrangement. Immunohistochemical staining was positive for CD34, bcl-2, and vimentin and negative for
alpha SMA and mesothelin. These results confirmed the diagnosis of SFT. Her hypoglycemic symptoms resolved
rapidly after surgery. The clinical course has since remained favorable with no signs of recurrence.
Conclusion: We report a case of non-islet cell tumor hypoglycemia caused by intrathoracic SFT. The high-
molecular-weight IGF-II produced by the tumor has been regarded as the cause of NICTH.
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Background
Non-islet cell tumor hypoglycemia (NICTH) is defined as
hypoglycemia caused by an extrapancreatic tumor.
NICTH can occur in patients with mesenchymal tumors,
hepatocellular carcinomas, and other extrapancreatic
tumors. Solitary fibrous tumor (SFT) associated with
hypoglycemia is rare at approximately 4 % [1, 2]. The
high-molecular-weight IGF-II produced by the tumor has
been regarded as the cause of NICTH [3, 4]. Herein, we
report a case with a surgically treated intrathoracic SFT,
diagnosed based on recurrent episodes of hypoglycemia.
Case presentation
A 76-year-old woman, who had frequently experienced
hypoglycemic symptoms such as presyncope for the
prior 6 months, visited the internal medicine department
of our hospital. Family history and past medical history
were unremarkable. Physical examination showed a
height of 155 cm, weight of 52 kg, blood pressure of
145/68 mmHg, and heart rate of 90 beats/min. There
were no remarkable findings except for diminished
breath sounds in the left middle and lower lobes of the
lung. Her fasting glucose level was low, at 49 mg/dl. Her
blood levels of IRI and C-peptide were also low at 0.2
μU/ml and 0.21 ng/ml, respectively. Chest radiography
showed a huge mass in the left thoracic cavity (Fig. 1).
Chest computed tomography revealed a mass measuring
15 cm with no invasion to the chest wall (Fig. 2). Posi-
tron emission tomography showed low FDG uptake in
the intrathoracic mass (a low SUV) (Fig. 3). There were
no lesions in other organs. Percutaneous needle biopsy
was performed and SFT was thus diagnosed. The patient
was diagnosed with intrathoracic SFT associated with
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NICTH and surgical treatment was planned. The tumor
was removed by video-assisted thoracoscopic surgery.
The excised specimen was a lobulated mass measuring
16 × 15 × 8 cm (Fig. 4). Histological examination showed
a tumor composed of simple spindle-shaped cells with
an irregular arrangement (Fig. 5). Immunohistochemical
staining was positive for CD34 (Fig. 6), bcl-2, and vimen-
tin, and negative for alpha SMA, mesothelin, s-100. The
diagnosis of SFT was thus confirmed. Her hypoglycemic
symptoms resolved rapidly after surgery. The clinical
course was favorable with no signs of recurrence.
Discussion
It is known that NICTH can occur in patients with
mesenchymal-derived tumors, hepatocellular carcin-
omas, and other extrapancreatic tumors. Approximately
4 % of SFTs are reportedly associated with hypoglycemia
[1–4]. NICTH is defined as hypoglycemia caused by a
non-beta islet cell tumor. This condition is often associ-
ated with excessive production of high-molecular-weight
IGF-II from the tumor and suppressed levels of serum
albumin and IGF-I [5, 6]. NICTH is diagnosed by detect-
ing the presence of an extrapancreatic tumor and by ex-
cluding other diseases that can cause hypoglycemia,
such as liver failure, adrenal failure, and insulinoma.
Although testing of high-molecular-weight IGF-II from
the tumor by the Western immunoblot method or gel-
filtration is more accurate for establishing the diagnosis,
these procedures often are not feasible in many routine
clinical settings. Therefore, the diagnosis is frequently
Fig. 1 Chest radiography shows a huge mass in the left
thoracic cavity
Fig. 2 Chest computed tomography reveals a mass measuring
15 cm with no invasion to the thoracic wall
Fig. 3 FDG-positron emission tomography shows low FDG uptake in
the intrathoracic mass (a low SUV)
Fig. 4 The excised specimen was a lobulated mass with dimensions
of 16 × 15 × 8 cm
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made based on the clinical course. In the present case,
although the production of high-molecular-weight IGF-
II from the tumor was not demonstrated, we considered
her hypoglycemia to be attributable to NICTH because
the patient had no other diseases that could have caused
hypoglycemia (such as the aforementioned liver failure,
adrenal failure, and insulinoma) and levels of IRI and C-
peptide were low. Furthermore, her hypoglycemic symp-
toms resolved rapidly after resection of the tumor.
Insulin-like growth factors (IGFs) consist of IGF-I and
IGF-II: IGD-I has important growth-promoting features
while IGF-II has an insulin-like hypoglycemic effect. The
normal-molecular-weight form of IGF-II is bound to
IGF-binding protein, forming a trimer. On the other
hand, in NICTH, high-molecular-weight IGF-II pro-
duced by the tumor forms a dimer which tends to result
in extravascular leakage and tissue penetration, leading
to hypoglycemia [7].
Resection of the primary tumor is the first-line treat-
ment for NICTH [8]. When curative resection is diffi-
cult, chemotherapy aimed at downsizing the tumor is a
potential treatment option. There are also reports
describing treatment with steroids or growth hormone
as being effective [9, 10]. Steroids are known to have an
effect not only on glycogen degradation and gluconeo-
genesis but also on the inhibition of IGF-II production,
although the underlying mechanism has yet to be eluci-
dated [11]. Further investigations are required to clarify
the mechanisms underlying the development of NICTH.
Conclusion
We report a case of non-islet cell tumor hypoglycemia
caused by intrathoracic SFT. The high-molecular-weight
IGF-II produced by the tumor has been regarded as the
cause of NICTH.
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